Ikena Oncology Statistics

Total Valuation

Ikena Oncology has a market cap or net worth of $65.63 million. The enterprise value is -$41.81 million.

Market Cap	65.63M
Enterprise Value	-41.81M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Ikena Oncology has 48.26 million shares outstanding. The number of shares has increased by 7.88% in one year.

Current Share Class	41.89M
Shares Outstanding	48.26M
Shares Change (YoY)	+7.88%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.52%
Owned by Institutions (%)	18.06%
Float	6.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.56
P/TBV Ratio	0.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.31, with a Debt / Equity ratio of 0.06.

Current Ratio	13.31
Quick Ratio	12.97
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -30.49% and return on invested capital (ROIC) is -20.81%.

Return on Equity (ROE)	-30.49%
Return on Assets (ROA)	-19.87%
Return on Invested Capital (ROIC)	-20.81%
Return on Capital Employed (ROCE)	-39.55%
Revenue Per Employee	n/a
Profits Per Employee	-$4.17M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Ikena Oncology has paid $153,000 in taxes.

Income Tax	153,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.07% in the last 52 weeks. The beta is 0.45, so Ikena Oncology's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	-17.07%
50-Day Moving Average	1.24
200-Day Moving Average	1.47
Relative Strength Index (RSI)	55.54
Average Volume (20 Days)	79,723

Short Selling Information

The latest short interest is 80,668, so 0.17% of the outstanding shares have been sold short.

Short Interest	80,668
Short Previous Month	80,124
Short % of Shares Out	0.17%
Short % of Float	1.32%
Short Ratio (days to cover)	0.78

Income Statement

Revenue	n/a
Gross Profit	-24.95M
Operating Income	-48.27M
Pretax Income	-66.78M
Net Income	-41.71M
EBITDA	-47.91M
EBIT	-48.27M
Earnings Per Share (EPS)	-$0.86

Full Income Statement

Balance Sheet

The company has $114.05 million in cash and $6.61 million in debt, giving a net cash position of $107.44 million or $2.23 per share.

Cash & Cash Equivalents	114.05M
Total Debt	6.61M
Net Cash	107.44M
Net Cash Per Share	$2.23
Equity (Book Value)	118.25M
Book Value Per Share	2.45
Working Capital	108.21M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-38.26M
Capital Expenditures	n/a
Free Cash Flow	-38.26M
FCF Per Share	-$0.79

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Ikena Oncology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.88%
Shareholder Yield	-7.88%
Earnings Yield	-63.55%
FCF Yield	-58.30%

Analyst Forecast

The average price target for Ikena Oncology is $4.00, which is 194.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.00
Price Target Difference	194.12%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1